Flagship Harbor Advisors’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
RI
ICM
Flagship Harbor Advisors's FLGT Position: Q1 2026 in Review
Flagship Harbor Advisors sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 2,120 shares — an estimated $55.7K sold.
Flagship Harbor Advisors first reported a position in FLGT in Q1 2020 and held it in 17 quarters. The position peaked at $959K in Q4 2021. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.
- Flagship Harbor Advisors reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
- Flagship Harbor Advisors sold 2,120 Fulgent Genetics shares in Q1 2026, an estimated $55.7K.
- Flagship Harbor Advisors first reported a position in Fulgent Genetics in Q1 2020 and held it in 17 quarters.
- Flagship Harbor Advisors's Fulgent Genetics position peaked at $959K in Q4 2021.
- 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.
Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.